Goldman, William

Goldman L, Weinstein MC, Goldman PA, Williams LW. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA 1991 265 1145-51. 

Lidow, MS, Williams, GV and Goldman-Rakic, PS (1998) The cerebral cortex a case for a common site of action of antipsychotics. Trends Pharmacol. Sci. 19 136-140. 

Williams TM, Ciccarone TM, MacTough SC, Rooney CS, Balani SK, Con-dra JH, Emini EA, Goldman ME, Greenlee WJ, Kauffman LR, O Brien JA, Sardana VV, Schleif WA, Theoharides AD, Anderson PS. 5-Chloro-3-(phe-nylsulfonyl)indole-2-carboxamide a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase. J Med Chem 1993 36 1291-1294. 

Williams S. M., Goldman-Rakic P. S. (1998). Widespread origin of the primate mesofrontal dopamine system. Cereb. Cortex 8(4), 321-45. 

John F. Bower Daniel Carmona Jongwook Choi Carmen Claver Robert H. Crabtree Montserrat Dieguez Alan S. Goldman John F. Hartwig Michael J. Krische Fuis A. Oro Oscar Pamies Andreas Pfaltz Mark J. Pouy Ourida Saidi Jonathan M. J. Williams David H. Woodmansee... 

Goldman-Rakic PS, Leranth C, Williams SM, Mons N, Geffard M (1989) Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex, Proc Natl Acad Sci USA 86 9015-9019... 

Brookhart Liu Organometallics 1989, 8, 1572,J. Am. Chem. Soc. 1991,113, 939 Brookhart Liu Goldman Timmers Williams J. Am. Chem. Soc. 1991, 113, 927 Lowenthal Abiko Masamune Tetrahedron Lett. 1990, 31, 6005 Evans Woerpcl Hinman Faul J. Am. Chem. Soc. 1991, 1/3, 726. For asymmetric Simmons-Smith reactions, sec Mori Arai Yamamoto Tetrahedron 1986, 42, 6447 Mash Nelson Heidt Tetrahedron Lett. 1987, 28, 1865 Sugimura Futagawa Yoshikawa Tai Tetrahedron Lett. 1989, 30, 3807. See also Ojima Clos Bastos, Ref. 232, pp. 6919-6921. 

Murcray, D.G., A. Goldman, F.H. Murcray, F.J. Murcray and W.J. Williams (1979) Stratospheric distribution ofClONOj. Geophysical Research Letters 6 857-859. 

Goldman-Rakic PS, Castner SA, Svensoon IH, Siever LJ, Williams GV Targeting the dopamine D1 receptor in schizophrenia insights for cognitive dysfunction. Psychopharmacology 2004 174 3-16. 

Castner SA, Goldman-Rakic PS, Williams GV. Animal models of working memory insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology 2004 174 111-125. 

Williams M, Goldman MB, Mittendorf R, Monson R (1991) Subfertility and the risk of low birthweight. Fertil Steril, 56 668-671. 

Castner SA, Williams GV, Goldman-Rakic PS. 2000. Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation [see comments]. Science 287 2020-2022. 

Goldman-Rakic PS, Muly EC III, Williams GV. 2000. D(l) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev 31 295-301. 

Constantinidis C, Williams GV,Goldman-Rakic PS. 2002. A role for inhibition in shaping the temporal flow of information in prefrontal cortex. Nat Neurosci 5 175-180. 

Similar results have been forthcoming from primate studies. Thus, D1 receptor antagonists administered iontophoretically to the PFC enhance, rather than impair, stimulus processing by single units in delayed saccade paradigms (Williams and Goldman-Rakic,... 

Williams GV, Goldman-Rakic PS (1995) Modulation of memory fields by DA D1 receptors in prefrontal cortex. Nature 376 512-515. 

Williams SM, Goldman-Rakic PS (1993) Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody. Cereb Cortex 3 199-222. 

---